medRxiv · Oct 24, 2026
Maternal epigenetic age acceleration in early pregnancy, gestational duration, and spontaneous preterm birth among Black women in the NuMom2b study
By Scorza P, Wu H, Reho P et al.
Importance: Preterm birth is a leading cause of neonatal morbidity and mortality and disproportionately affects Black birthing people in the United States. DNA methylation based measures of biological aging may capture physiologic dysregulation relevant to birth timing. We aim to determine whether maternal epigenetic age acceleration in early pregnancy is associated with gestational duration, spontaneous preterm birth (sPTB), and small for gestational age (SGA) among Black nulliparous pregnant individuals. Methods: This is a secondary data analysis of the prospective, multicenter Nulliparous Pregnancy Outcomes Study: Monitoring Mothers-to-Be (nuMoM2b). Participants enrolled in eight US clinical research sites from 2010 to 2014 were followed through delivery; DNAm arrays were processed in 2024, and the current analysis was conducted in 2026. Participants were nulliparous individuals with singleton pregnancies who self-identified as Black. Maternal peripheral blood DNA methylation was measured at 6 to13 weeks of gestation using the Illumina MethylationEPIC array. The primary aging metric was standardized GrimAge2 age acceleration. Principal Components versions of the Horvath, Hannum, PhenoAge, GrimAge, and DNAmTL clocks, and DunedinPACE, were used in additional analyses. Delivery data was abstracted from medical records in the NuMom2b study. Outcomes were gestational duration in days, based on the best obstetric estimate, adjudicated sPTB before 37 completed weeks, and SGA. Primary linear and logistic regression models adjusted for maternal age, smoking, gestational age at blood draw, and estimated blood cell composition. Secondary models added education and body mass index (BMI) as additional covariates. Fetal sex interaction effects were tested. Results: Among 931 participants (mean age = 23.46 [SD=5.33] years), 55 (5.9%) experienced sPTB. Each 1-SD higher GrimAge2 acceleration was associated with 1.32 fewer days of gestation (b = -1.32 days; 95% CI, -2.36 to -0.28; P=.01) and higher odds of sPTB (odds ratio, 1.51; 95% CI, 1.13-2.02; P=.01). Results were slightly attenuated but remained significant for sPTB when controlling for education and BMI. Epigenetic age acceleration was not associated with SGA. Results were not significantly different by fetal sex. Conclusions and Relevance: Greater first-trimester maternal GrimAge2 acceleration was associated with shorter gestation and 51% higher odds of sPTB but was not associated with SGA among Black nulliparous participants. The association with sPTB persisted after adjustment for socioeconomic and metabolic characteristics, warranting further evaluation of whether GrimAge2 improves early-pregnancy prediction of sPTB value beyond these factors.